Kardigan, Inc. (KARD) stock
KARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$12.32−0.87 (-6.60%)
Close on Nov 18, 2026Market cap $1.15BP/E –Yield –
Kardigan net income
Net income is the profit left for shareholders after every expense, interest and tax.
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$58.57M | – |
| Q2 FY2026 | Jun 30, 2026 | -$116.24M | – |
| Q1 FY2026 | Mar 31, 2026 | -$56.07M | – |
| Q3 FY2025 | Sep 30, 2025 | -$60.16M | – |
| Q2 FY2025 | Jun 30, 2025 | -$57.45M | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.02M | – |
See a number that looks wrong?